300244 迪安診斷
按盤價 
18.870 -0.500 (-2.581%)
18.870 -0.500 (-2.581%) | 2025/12 - 人民幣(K¥) | 變動 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 10,096,032 | -17.22% | 13,408,320 | 20,282,469 | 13,082,613 | 10,649,162 | |
| 減：營業總成本 | 9,550,981 | -16.25% | 12,243,282 | 16,603,821 | 11,084,409 | 8,862,648 | |
| 其中:營業成本 | 7,222,146 | -17.74% | 9,213,383 | 12,745,811 | 8,076,949 | 6,578,706 | |
| 財務費用 | 156,601 | -20.92% | 220,608 | 298,236 | 217,479 | 195,875 | |
| 資產減值損失 | (96,289) | -76.02% | (16,738) | (624,025) | (272,189) | (475,247) | |
| 公允價值變動收益 | 3,528 | -127.78% | (727) | (56,236) | 83,354 | (2,586) | |
| 投資收益 | 26,194 | -32.34% | (17,596) | 48,787 | 55,338 | 73,148 | |
| 其中：對聯營企業和合營企業的投資收益 | 18,040 | 55.73% | (6,722) | 26,763 | 39,785 | 20,783 | |
| 營業利潤 | 281,315 | -1,004.11% | 842,183 | 2,822,609 | 1,837,935 | 1,320,311 | |
| 利潤總額 | 256,190 | -594.32% | 798,326 | 2,543,562 | 1,790,997 | 1,317,395 | |
| 減：所得稅費用 | 110,584 | -5.81% | 216,735 | 681,092 | 307,396 | 247,461 | |
| 淨利潤 | 145,606 | -186.04% | 581,591 | 1,862,470 | 1,483,601 | 1,069,934 | |
| 減：非控股權益 | 101,554 | -45.99% | 274,130 | 428,279 | 320,717 | 267,002 | |
| 股東淨利潤 | 44,053 | -112.33% | 307,461 | 1,434,191 | 1,162,884 | 802,933 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.072 | -112.45% | 0.492 | 2.302 | 1.874 | 1.294 | |
| 每股派息 (元) * | 0.350 | -61.11% | 0.060 | 0.200 | 0.135 | 0.130 | |
| 每股淨資產 (元) * | 10.308 | -1.86% | 12.069 | 11.881 | 9.416 | 7.572 | |
| 審計意見 # | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 24/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
